New study seeks clues to slow kidney disease progression
NCT ID NCT04344769
First seen Jan 17, 2026 · Last updated May 19, 2026 · Updated 19 times
Summary
This study looks at how the body handles oxidative stress in people with early-stage autosomal dominant polycystic kidney disease (ADPKD). Researchers will measure markers of damage and antioxidant activity in blood and urine, and use MRI to measure kidney size. The goal is to find new biomarkers that could help track or treat the disease earlier. About 40 participants aged 18-30 with ADPKD and good kidney function will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.